FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

129488003: Eprosartan mesilate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
208270013 Eprosartan mesylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2691864018 Eprosartan mesilate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3725572013 Eprosartan mesilate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
31111000188114 éprosartan mésilate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eprosartan mesilate Is a Product containing angiotensin II receptor antagonist (product) false Inferred relationship Some
Eprosartan mesilate Is a Angiotensin II receptor antagonist true Inferred relationship Some
Eprosartan mesilate Is a Eprosartan (substance) false Inferred relationship Some
Eprosartan mesilate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Angiotensin II receptor antagonist (disposition) true Inferred relationship Some
Eprosartan mesilate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Eprosartan (substance) true Inferred relationship Some
Eprosartan mesilate Is a Imidazole true Inferred relationship Some
Eprosartan mesilate Is a Thiophene true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Eprosartan mesylate 400mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some
Eprosartan mesylate 600mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some
Eprosartan (as eprosartan mesilate) 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some
Eprosartan (as eprosartan mesilate) 600 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some
Product containing eprosartan and hydrochlorothiazide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some
Eprosartan (as eprosartan mesilate) 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some
Eprosartan (as eprosartan mesilate) 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some 1
Eprosartan (as eprosartan mesilate) 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some 1
Eprosartan (as eprosartan mesilate) 600 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some 1
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Eprosartan mesilate Inferred relationship Some 1
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some 2
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Eprosartan mesilate Inferred relationship Some 2
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Eprosartan mesilate Inferred relationship Some 2
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Eprosartan mesilate Inferred relationship Some 2
Eprosartan (as eprosartan mesilate) 300 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Eprosartan mesilate Inferred relationship Some 1
Eprosartan (as eprosartan mesilate) 400 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Eprosartan mesilate Inferred relationship Some 1
Eprosartan (as eprosartan mesilate) 600 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Eprosartan mesilate Inferred relationship Some 1
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Eprosartan mesilate Inferred relationship Some 2
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Eprosartan mesilate Inferred relationship Some 1
Eprosartan (as eprosartan mesilate) 600 mg and hydrochlorothiazide 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Eprosartan mesilate Inferred relationship Some 2
Product containing precisely eprosartan (as eprosartan mesilate) 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Eprosartan mesilate Inferred relationship Some 2

This concept is not in any reference sets

Back to Start